<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04672109</url>
  </required_header>
  <id_info>
    <org_study_id>MU2020</org_study_id>
    <nct_id>NCT04672109</nct_id>
  </id_info>
  <brief_title>The Effects of Different Montages of tDCS on Muscle Strength in Healthy Adults</brief_title>
  <official_title>The Effects of Different Montages of Transcranial Direct Current Stimulation on Muscle Strength in Healthy Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the effects of different montages of tDCS on muscle strength in healthy adults&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Electrode montage or placement of tDCS over primary motor cortex can be categorized into&#xD;
      unilateral (anodal or cathodal electrode over primary motor area) and bilateral tDCS (both&#xD;
      anodal and cathodal electrode over the cortex). Previous studies reported benefits of&#xD;
      different tDCS montages on muscle performance in healthy participants. However, there is no&#xD;
      guideline for tDCS montages. This study aims to investigate immediate effects of different&#xD;
      tDCS montages on muscle strength in healthy participants.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 16, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline muscle strength after tDCS</measure>
    <time_frame>Baseline (Pretest) and 40 minutes ( posttest)</time_frame>
    <description>Muscle strength will be measured in Newton by using a hand-held dynamometer.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">188</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Anodal-tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anodal transcranial direct current stimulation (tDCS) will be applied for 20 mins. Anode on the primary motor area (M1) of dominant hemisphere and Cathode on the supraorbital area of non-dominant hemisphere. Current intensity is fixed at 2 mA and current will flow continuously. The scope of intervention is to investigate effect of tDCS on muscle strength.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cathodal-tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cathodal transcranial direct current stimulation (tDCS) will be applied for 20 mins. Cathode on the primary motor area (M1) of non-dominant hemisphere and Anode on the supraorbital area of dominant hemisphere. Current intensity is fixed at 2 mA and current will flow continuously. The scope of intervention is to investigate effect of tDCS on muscle strength.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dual-tDCS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dual transcranial direct current stimulation (tDCS) will be applied for 20 mins. Anode on the primary motor area (M1) of dominant hemisphere and Cathode on the primary motor area of non-dominant hemisphere. Current intensity is fixed at 2 mA and current will flow continuously. The scope of intervention is to investigate effect of tDCS on muscle strength.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham-tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Dual transcranial direct current stimulation (tDCS) will be applied over C3-C4 or the motor area (M1) for 20 mins. Anode on dominant hemisphere, Cathode on non-dominant hemisphere. The scope of intervention is to investigate effect of tDCS on muscle strength.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial direct current stimulation</intervention_name>
    <description>Dual/Cathodal/Anodal/Sham tDCS will be applied in 2 mA, 20 mins. All experiments will be performed in random order for each subject.</description>
    <arm_group_label>Anodal-tDCS</arm_group_label>
    <arm_group_label>Cathodal-tDCS</arm_group_label>
    <arm_group_label>Dual-tDCS</arm_group_label>
    <arm_group_label>Sham-tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Healthy adults&#xD;
&#xD;
          2. Age range between 18 - 60 years old&#xD;
&#xD;
          3. Right-handed dominant identified by the Edinburg Handedness Inventory&#xD;
&#xD;
          4. No recent muscle injuries of both limbs for a past 6-months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Consumed caffeine within 24 hours prior the experiment&#xD;
&#xD;
          2. History of neurological symptoms i.e. seizures, weakness, loss of sensation or unclear&#xD;
             history of pass illness&#xD;
&#xD;
          3. Present of metal implantation, intracranial shunt, cochlear implantation or cardiac&#xD;
             pacemakers&#xD;
&#xD;
          4. Present of opened wound or infectious wound around scalp&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wanalee Klomjai, PhD</last_name>
    <role>Study Director</role>
    <affiliation>MU</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wanalee Klomjai, PhD</last_name>
    <phone>+66926194556</phone>
    <email>wanalee.klo@mahidol.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Physical Therapy, Mahidol University</name>
      <address>
        <city>Salaya</city>
        <state>Nakhon Pathom</state>
        <zip>73170</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wanalee Klomjai, PhD</last_name>
      <phone>+6624415450</phone>
      <phone_ext>20216</phone_ext>
      <email>wanalee.klo@mahidol.edu</email>
    </contact>
    <investigator>
      <last_name>Wanalee Klomjai, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benchaporn Aneksan, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Oranich Vimolratana, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 9, 2020</study_first_submitted>
  <study_first_submitted_qc>December 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>December 16, 2020</last_update_submitted>
  <last_update_submitted_qc>December 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

